Dr Almarzooqi is the Co-Founder and Managing director at meta[bolic] and GluCare Health, a hybrid healthcare company focused on metabolic disease which became the first healthcare provider to be accredited by the International Consortium for Health outcomes measures (ICHOM) and the only hybrid healthcare model endorsed by the American Diabetes Association.
He was included in the Forbes list for top healthcare leaders (2023).

From 2008-2017, Dr. Ihsan Al Marzooqi served as Director and Deputy Head at Mubadala Healthcare and served as Vice-Chairman of the Board of Directors for Healthpoint, Imperial College London Diabetes Centre, National Reference Laboratory, Tawam Molecular Imaging Centre and Capital Health Screening Centre. He mandated the introduction of public clinical outcome reporting in the UAE.
He previously served as board member at Cleveland Clinic Abu Dhabi.

Dr. Al Marzooqi earned his Ph.D. from University College London, focusing on gene therapy applications. He also holds a Master of Science in Biochemical Engineering from University College London, a Bachelors of Engineering in Chemical Engineering from the University of Sheffield, and a Masters of Business Administration from London Business School.